In a new article in the journal Cancer, a research group associated primarily with the University of California, Los Angeles, have provided detailed information on the costs of first-line management of low-risk prostate cancer. The paper by Laviana et al., along with a media release from UCLA Health, indicate wide variation in the costs for […]![]()
